ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

186 hedge funds and large institutions have $2.05B invested in Acorda Therapeutics in 2015 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 67 increasing their positions, 70 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

4% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 70

26% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $13.8M

Holders
186
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$10.2M
Puts
$13.8M
Net Calls
Net Calls Change

Top Sellers

1 -$79.5M
2 -$39.8M
3 -$14M
4
JGC
J. Goldman & Co
New York
-$10.5M
5
Barclays
Barclays
United Kingdom
-$10.5M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$1.51M
102
$1.49M
103
$1.43M
104
$1.42M
105
$1.35M
106
$1.34M
107
$1.3M
108
$1.3M
109
$1.28M
110
$1.28M
111
$1.2M
112
$1.18M
113
$1.17M
114
$1.08M
115
$1.05M
116
$1.02M
117
$938K
118
$920K
119
$885K
120
$867K
121
$817K
122
$794K
123
$791K
124
$785K
125
$762K